NCT05843786View on ClinicalTrials.gov

Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

July 30, 2025

Study Completion Date

July 30, 2025

Conditions
Pneumonia, Ventilator-Associated
Interventions
DRUG

Interferon gamma

Daily subcutaneous administration of Interferon gamma during 5 days

DRUG

Placebo

Placebo during 5 days

Trial Locations (9)

42055

NOT_YET_RECRUITING

Département Anesthésie-Réanimation, Saint-Etienne

54511

NOT_YET_RECRUITING

Service d'anesthésie-réanimation, unité de réanimation chirurgicale Picard, Nancy

69003

RECRUITING

Service civilo-militaire d'Anesthésie-Réanimation et Médecine Périopératoire, Lyon

69004

NOT_YET_RECRUITING

Service de reanimation chirurgicale Hopital Croix-Rousse, Lyon

RECRUITING

Service de reanimation médicale hôpital de la Croix-Rousse, Lyon

69395

RECRUITING

Service d'Anesthésie-réanimation-médecine intensive Hôpital Lyon Sud, Pierre-Bénite

75014

NOT_YET_RECRUITING

Médecine intensive- Réanimation, Paris

Unknown

NOT_YET_RECRUITING

CHU Limoges, Limoges

NOT_YET_RECRUITING

Hôpital Edouard Herriot - Médecine intensive - réanimation, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER